About us
At Purple MicroPort the team is dedicated to address unmet needs in the field of cardiovascular disease. We are committed to bring innovative ideas, products and services to improve the health and well-being of people.
Our scientific & therapeutic knowledge has helped us to address the most challenging healthcare issues efficiently.
2007
MIV Therapeutics (India) Pvt. Ltd. Entered into a marketing tie up with Purple Medical Solutions (India) Pvt. Ltd with focus on Domestic sales
2011
Purple Medical Solution Pvt. Ltd, acquired MIV Therapeutics (India) Pvt. Ltd. for both domestic and global operations
2020
In March, Purple entered into a joint venture with MicroPort to form Purple MicroPort Cardiovascular.
Leadership Team:
Brian Lancelot
CEO
Brian has worked for 10 years in an MNC pharmaceutical company before moving to the medical device industry in 2002.
Dinesh Arora
Vice President & Deputy CEO
Dinesh Brings with him 20 years of experience of Medical Device across different functions Vis Sales, Marketing, HR, P&L and Strategy.
Abhijit Patwardhan
Chief Finance Officer
Abhijit has around 20 years of professional experience across various finance verticals like Financial & strategic planning/Analysis, Corporate accounting & Finance, treasury operations, commercial finance, Internal controls & risk management, M&A ,Taxation etc.
Rajesh Shrivas
Director Manufacturing
Rajesh comes with a vast breadth of sales and marketing experience spread over 25 years of having worked in Pharma and Medical device sector with leading MNC’s.
Murlidhar Bendale
Director Sales Support
Murlidhar has more than 25 years’ experience across the Medical Devices and Medical Equipment Industry. Founder Member of Purple Medical Solutions (2007)
Mathew T Thomas
Director HR & Commercial
Mathew has more than 20 year of Pharma and medical device experience. Founding Member of Purple Medical Solutions (2007). A Pharmacist by learning with a sales and Marketing specialization in Management.
Funding
Self-funded (bootstrapped) company without external investments.